Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care
Authors
E. Richard
S. A. Ligthart
E. P. Moll van Charante
W. A. van Gool
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 4/2010
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-010-0072-3

Other articles of this Issue 4/2010

The journal of nutrition, health & aging 4/2010 Go to the issue

OriginalPaper

Study design considerations: Conducting global clinical trials in early Alzheimer’s disease

OriginalPaper

Which generic health related quality of life questionnaire should be used in older inpatients: Comparison of the duke health profile and the MOS short-form SF-36?

OriginalPaper

Short-term influence of elevation of plasma homocysteine levels on cognitive function in young healthy adults

OriginalPaper

Does chair type influence outcome in the timed “up and go” test in older persons?

OriginalPaper

Clinical trials for early (pre-dementia) Alzheimer’s disease: A case for mild cognitive impairment

OriginalPaper

The potential and limits for clinical trials for early Alzheimer’s disease and some recommendations

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits